Recombinant adeno-associated virus-, polyethylenimine/plasmid- and lipofectamine/carboxyfluorescein-labeled small interfering RNA-based transfection in retinal pigment epithelial cells with ultrasound and/or SonoVue
- Authors:
- Published online on: January 19, 2015 https://doi.org/10.3892/mmr.2015.3219
- Pages: 3609-3614
Abstract
Introduction
A variety of genetic diseases of the retina, including retinitis pigmentosa, leber congenital amaurosis and proliferative vitreoretinopathy are associated with disorder of retinal pigment epithelial (RPE) cells. To date, no satisfactory treatments for these disorders have been identified. Gene therapy is a promising therapeutic option for these diseases. RPE cells are a potential target for treatment with gene delivery, since they are able to secrete transgenes to the neural retina following in vivo transfection and they may be transfected in vitro and then re-implanted into the eye (1,2). Non-viral gene delivery to RPE cells has shown limited success due to its relatively low efficiency. RPE cells are a type of cell which is difficult to transfect (3–6). Polyethylenimine (PEI), which is considered to be the gold standard polymeric transfection reagent, only achieved 8% transfection efficiency in APRE-19 cells in a previous study (3). Thus, the major challenge is to identify an effective delivery system with improved performance in RPE cells.
In 1987, Fechheimer et al (7) proposed that ultrasound may promote gene transfection in vitro. Ultrasound-targeted microbubble destruction (UTMD) has been shown to be safe and efficient for use in various organs. However, the mechanisms by which US-mediated transfection (USMT) or UTMD enhance gene transfection have yet to be elucidated. Sonoporation is considered to be the principal factor. In the field of ophthalmology, a number of studies have investigated the effects of USMT or UTMD on the cornea. However, there are far fewer reports on these treatments in the retina (8–12). Despite previous studies by this group on UTMD-mediated recombinant adeno-associated virus and plasmidDNA delivery to APRE-19 cells (12–14), there is little information on the effect of UTMD in RPE cells (8). A previous study showed that UTMD increased recombinant adeno-associated virus transfection efficiency to APRE-19 cells by ~75% with 97.38±3.16% cell viability (12). Nearly all studies on UTMD and gene transfer have evaluated cell viability in response to different techniques and at various time-points (7–14). However, the optimal time at which to accurately assess the effect of UTMD on cell viability is yet to be determined. Therefore, in the present study, cell viability at 0 and 24 h following UTMD, as well as the effectiveness of UTMD in promoting type 2 recombinant adeno-associated virus vector encoding the enhanced green fluorescence protein (EGFP) gene (rAAV), polyethylenimine (PEI)/plasmid (p)DNA and lipofectamine (L)/carboxyfluorescein (FAM)-labeled siRNA (L/siRNA) transfection, were studied. Studies on different genes (including pDNA and siRNA) and in different types of vectors (chemical and biological) mediated by UTMD may provide useful information to guide future developments in this field.
Materials and methods
Cell culture
The human ARPE-19 RPE cell line was obtained from the American Type Culture Collection (CRL-2302, Rockville, MD, USA). Cells were cultured 1:1 in Dulbecco’s modified Eagle’s medium (DMEM)/F12 with 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco Laboratories, Gaithersburg, MD, USA) for the rAAV and PEI/pDNA transfections, and in medium without penicillin for the siRNA transfection. RPE cells were placed into every other well of 24-well plates, at a concentration of 2×105 cells per well prior to infection.
Ultrasound contrast agent, rAAV, PEI/pDNA and L/siRNA
SonoVue microbubble (MB) contrast agent
SonoVue microbubble contrast agent (Bracco, Milan, Italy) was reconstituted in 5 ml saline solution according to the manufacturer’s instructions. SonoVue microbubbles are lipid shells filled with sulfur hexafluoride gas, containing ~2–5×108 microbubbles/ml and with an average diameter of 2.5–6.0 μm. A quantity of 2×108 MBs/ml was taken as a basis for calculating the MB/cell ratio.
rAAV2
rAAV2-EGFP [1×1012 vector genomes (vg)/ml] was obtained from Vector Gene Technology Co., Ltd. (Beijing, China). A dose of 1×103 MOI (multiplicity of infection; vector genomes/number of cells) was used.
siRNA
FAM-labeled siRNA was obtained from GenePharma Co., Ltd. (Shanghai, China). The concentration used was 20 nM. Lipofectamine™ 2000 was purchased from Invitrogen Life Technologies (Carlsbad, CA, USA). L (1 μl/well) was diluted with 50 μl opti-minimum essential medium (MEM) I Reduced Serum medium (Gibco Laboratories) and incubated at room temperature for 5 min. siRNA (1 μl/well) was diluted with 25 μl opti-MEMI Reduced Serum medium. Incubated diluted L was mixed with diluted siRNA and maintained at room temperature for 20 min in order to obtain the L/siRNA mixture.
Branched PEI
PEI (molecular weight, 25 kDa) was obtained from Sigma-Aldrich (St. Louis, MO, USA). The 4.7-kb plasmid EGFP-N1 (1 μg/μl) was extracted and identified according to the manufacturer’s instructions (Plasmid Maxi Preparation kit; Qiagen, Valencia, CA, USA). An N/P ratio of 8 and a pDNA concentration of 1 μg/cell was used. This was maintained for 20 min at room temperature once PEI was mixed with pDNA.
Cell damage assay
RPE cells were seeded into 48 wells of a 96-well plate (with four adjacent wells as a group separated by gaps of four blank wells) at a concentration of 1×105 cells per well. Cells were exposed to US with various parameters (frequency, 1 MHz; intensity, 1, 2 or 3 W/cm2; duration, 60 or 120 sec; duty cycle, 20, 50 or 100%) with or without SonoVue (MB/cell ratio, 20:1, 50:1 or 70:1). The final volume per well during exposure to US was 100 μl, including DMEM and SonoVue. At 0 and 24 h following administration of UTMD with various exposure parameters, tryptan blue (Invitrogen Life Technologies) and MTS assays (AQueous One Solution Cell Proliferation Assay kit; Promega Corp., Madison, WI, USA) were performed.
Ultrasound exposure protocol
Cells were seeded onto a 24-well plate at a volume of 200 μl per well during exposure to US, including DMEM, rAAV, PEI/pDNA and L/siRNA. In order to attach rAAV, PEI/pDNA or L/siRNA to MBs, the mixture was incubated at room temperature for 5 min, with or without SonoVue (MB/cell ratio, 50:1), to allow for the development of an electrostatic attachment. The mixed solution was added to the plates which were then exposed to US. At 2 h post-infection, the plates were supplemented with DMEM to achieve a final volume of 500 μl. At 12 h following infection, the solution was replaced with fresh DMEM.
A therapeutic US machine (Topteam161; Chattanooga Medical Supply, Inc., Chattanooga, TN, USA) was used as previously described (12). The following experimental conditions were used for the transfection experiments: Frequency, 1 MHz; US intensity, 1 W/cm2; duration, 60 sec; pulse wave with 50% duty cycle; SonoVue dose, negative; and MB/cell ratio, 50:1. RPE cells were infected by rAAV, PEI/pDNA and L/siRNA alone or in combination with US, SonoVue or UTMD treatment. Cells infected by rAAV, PEI/pDNA and L/siRNA alone served as control groups.
Gene transfer efficiency
At 48 h following rAAV and PEI/pDNA transfection, and at 12 h following L/siRNA transfection, EGFP or FAM expression was observed and images were captured using inverted fluorescence microscopy (Zeiss Axiovert S100; Zeiss, Oberkochen, Germany). The percentage of infected cells and the mean fluorescence density were examined by fluorescence-activated cell sorting (EPICS XL; Beckman Coulter, Miami, FL, USA).
Effect of UTMD on pDNA, rAAV, PEI/pDNA and L/siRNA
The effect of UTMD on the structure of pDNA in the supernatant was evaluated by agarose gel electrophoresis. The effects of UTMD parameters on rAAV, PEI/pDNA and L/siRNA were evaluated by assessing the transfection efficiency of the cells following UTMD. Medium (200 μl) containing rAAV, PEI/pDNA or L/siRNA only was exposed to UTMD and the percentage of infected cells was then evaluated. The UTMD conditions used were: 1 W/cm2; 50% duty cycle; 60 sec; and MB/cell ratio, 50:1.
Statistical analysis
Values are expressed as the mean ± standard deviation. Cell viability conditions were performed in twelve parallel wells. All transfection conditions were performed in three parallel wells, following identical procedure and repeated thrice. For data following a Gaussian (normal) distribution, an unpaired Student’s t-test was used to determine the significance of the difference between two groups. If not, a nonparametric Mann-Whitney test was used. One way analysis of variance was employed to determine the significance of the differences in multiple comparisons. P<0.05 was considered to indicate a statistically significant difference. The software package used was GraphPad Prism, version 5.0 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Comparison of cell viability 24 h post-UTMD with various exposure parameters
As shown in Fig. 1A–D, the effects of various UTMD conditions on RPE cell morphology were observed using a light microscope. Untreated RPE cells presented an adherent monolayer shape (Fig. 1A), and following an increase in energy, the cellular morphology turned round or irregular (Fig. 1B–D). In addition, under the combination of upper limit parameters, cellular morphology turned irregular and the cytoplasm showed poor refractivity with a ground glass appearance (Fig. 1D).
Cell viability assays
Comparison of cell viability at 0 and 24 h following UTMD
US intensity and exposure durationUS intensity was varied between 1, 2 and 3 W/cm2. The duration of exposure was varied between 60 and 120 sec. The MB/cell ratio was 50:1 and the duty cycle was 50%. Cell viability at 24 h was lower than that immediately post-UTMD in all subgroups, although the difference was not significant at 1 or 2 W/cm2. At an US intensity of 3 W/cm2 and a duration of 60 or 120 sec, the cell viability was significantly reduced at 24 h compared with that at 0 h (P=0.0021 and 0.019, respectively; Fig. 1E and F).
Duty cycleThe duty cycle was varied between 20, 50 and 100%, with an MB/cell ratio of 50:1, a duration of 60 sec and an intensity of 1 W/cm2. Using a 100% duty cycle, the cell viability at 24 h was significantly lower than that immediately following UTMD (P<0.001; Fig. 1G).
Dosage of SonoVueThe MB/cell ratio varied between 20:1, 50:1 and 70:1 at a duration of 60 sec, a duty cycle of 50% and an intensity of 1 W/cm2. At an MB/cell ratio of 70:1, cell viability at 24 h was significantly lower than that at 0 h post-UTMD (P=0.0281; Fig. 1H).
US intensity and duration of exposureUS intensity was varied between 1, 2 and 3 W/cm2 with a duration of 60 sec. Cell viability at an intensity of 3 W/cm2 was significantly lower than that at 1 W/cm2 (P<0.001, Fig. 1I). Intensities of 1, 2 and 3 W/cm2 were applied at a duration of 120 sec. Cell viability was shown to decrease in an intensity-dependent manner. Cell viability at an intensity of 3 W/cm2 was significantly lower than that at 1 or 2 W/cm2 (P<0.001; Fig. 1J).
Duty cycleA duty cycle of 100% significantly reduced cell viability compared with that in the 20% and 50% duty cycle groups (P<0.001; Fig. 1K). There was no significant difference in the cell viability with duty cycles of 20%and 50% (P>0.05).
Dosage of SonoVueAn MB/cell ratio of 70:1 significantly damaged cells compared with ratios of 20:1 and 50:1 (P<0.001, respectively; Fig. 1L). There was no significant difference in cell viability between the 20:1 and 50:1 groups (P>0.05).
Transfection of PEI/pDNA-, L/siRNA- or rAAV of RPE cells using US and/or SonoVue
Gene transfer by US
The ratio of positively transfected cells and the mean fluorescence density were compared between the different groups (Fig. 2). There were no differences in the ratios of positively transfected cells or the mean fluorescence densities between the US exposure groups and the corresponding control groups for rAAV and PEI/pDNA. In the L/siRNA group, the ratio of positively transfected cells and the mean fluorescence density were significantly higher than those of the control group (P<0.001; Fig. 2D and E).
Gene transfer by SonoVue
There were no significant differences in the percentages of positively transfected cells and the mean fluorescence densities between the SonoVue groups and the corresponding control groups for the rAAV, PEI/pDNA and L/siRNA vectors (P>0.05 for all; Fig. 2F and G).
Gene transfer by US and SonoVue
In the rAAV, PEI/pDNA and L/siRNA groups, UTMD significantly enhanced the percentage of positively transfected cells compared with those in the control groups (P<0.001, P<0.001 and P=0.0244, respectively; Fig. 2H). The mean fluorescence density was significantly higher than that of the corresponding control groups for rAAV and PEI/pDNA (P<0.001 and P=0.0004, respectively; Fig. 2I).
Comparison of the increased transfection efficiency among UTMD/rAAV, UTMD/PEI/pDNA and US/L/siRNA groups
The increased percentage of positively transfected cells in the UTMD/rAAV and UTMD/PEI/pDNA groups was significantly higher than that in the US/L/siRNA group (P<0.001 and P=0.001, respectively; Fig. 2J). The increased percentage of the mean fluorescence density in the UTMD/PEI/pDNA group was significantly higher than that in the UTMD/rAAV and US/L/siRNA groups (P=0.011 and 0.009, respectively; Fig. 2K).
Effect of UTMD on pDNA, rAAV, PEI/pDNA and L/siRNA
Agarose gel electrophoresis was used to evaluate the structure of pDNA in the supernatant following exposure to UTMD and compared with that without treatment. The migration rate during electrophoresis of the EGFP plasmid remained unchanged, with supercoiled DNA remaining dominant in the electrophoresis band, and the optical density of supercoiled DNA in the same lane showing no significant change (Fig. 3A). The effect of UTMD on the transfection efficacy of rAAV, PEI/pDNA and L/siRNA in cells was studied (Fig. 3B). There was no significant difference between the experimental groups and the corresponding control groups (P>0.05).
Discussion
Considering the significant morbidity of numerous refractory retinal diseases and the limitations of the available treatment, the advancement of gene therapy is a promising development in this field. RPE maintains the function of the photoreceptors and is an important target in retinal gene delivery. Studies in non-viral gene delivery approaches have reported limited success in the transfection of RPE cells in vitro. One study using solid lipid nanoparticles to transfect ARPE-19 cells only achieved 2.5% efficacy (4). The most effective reagent identified in another study achieved only 12–15% efficiency even when it optimized a number of different commercially available reagents for the transfection of ARPE-19 cells (6). A further study into the transfection of RPE cells reported <1% for Lipofectin, 1–3% for DOTAP/DOGS and <5% using degraded dendrimers (5). RPE cells are considered a cell type which is difficult to be transfected (3–6,15). A novel method of delivery is thus required to augment the efficiency of gene transfer to ARPE-19 cells.
pDNA or siRNA are degraded enzymatically in the body, and UTMD remains to have a low proficiency in promoting transfection (16–18). In order to enhance the efficiency of transfection, UTMD may be combined with other transfection methods. UTMD has been shown to enhance liposomal-, PEI- and adeno-associated virus-mediated gene transfer in vitro and in vivo (16–18). To the best of our knowledge there is no information on UTMD-mediated non-viral vector transfection of RPE cells. In the present study, the efficiency of UTMD combined with PEI/pDNA, L/siRNA and rAAV in promoting transfection in RPE cells was investigated.
To establish the optimal conditions for UTMD-mediated gene transfer to RPE cells, the effects of various conditions on cell viability at 0 and 24 h following UTMD were examined. Through the vibration and burst of microbubbles, ultrasonic cavitation produces a mechanical shearing force, forms free radicals, increases the intracellular calcium concentration and causes damage to the mitochondrial membrane (16–19). The series of sonochemical reactions produced may cause the loss of function, dissolution or death of cells. The present study showed that the majority of cells did not die immediately following UTMD, but that UTMD affected the microstructure inside the cells, and thus inhibited cell proliferation. Therefore, cell viability at 24 h was lower than that immediately following UTMD. Cell viability at 24 h following UTMD using various exposure parameters was also investigated. Different UTMD parameters may have different effects on the cells, possibly due to certain irradiation parameters leading to cell membrane fatigue, so that the corresponding position of the cell membrane was damaged. The results indicated that cell viability evaluation at 24 h post-UTMD provided a more accurate result than immediate assessment following UTMD. In addition, an US intensity of 3 W/cm2, a 100% duty cycle and an MB/cell ratio of 70:1 caused significant damage to the cells and should therefore not be used in future investigations. Furthermore, the combination of parameters used in the transfection experiments was safe as cell viability at 24 h was 97.88%.
A preliminary study by our group produced an optimized method for the delivery of rAAV (12–14), PEI/pDNA and L/siRNA into RPE cells, including the optimized US exposure parameters, the N/P ratio and the dosage of L and siRNA (data not shown). The present study evaluated the efficiency (as measured by the percentage of positively transfected cells and the mean fluorescence density) of UTMD combined with PEI/pDNA, L/siRNA and rAAV in enhancing transfection in RPE cells. The results showed that rAAV and PEI/pDNA with US exposure alone did not increase transfection efficiency, whereas US markedly increased L/siRNA transfection efficiency. The majority of studies have shown that USMT enhanced gene transfer efficiency. However, in the present study, USMT did not increase the transfer efficiency of rAAV and PEI/pDNA. One study that investigated the mechanisms by which UTMD increases AAV transfection suggested that sonoporation enabled AAV to gain direct access to the cell cytoplasm (19). The energy of USMT, as opposed to that of UTMD, may be insufficient for the formation of sonoporation in RPE cells. USMT was shown to increase L/siRNA transfection efficiency. At lower ultrasound energy levels, oscillation occurs in the vicinity of cells and gently agitates the cell membrane. This phenomenon has been demonstrated in different studies and the process is not known to induce endocytosis (20,21). In order for the transfection of liposomes to occur, they fuse with the plasma membrane and enter the cell by endocytosis (20,21). It is possible that the endocytosis generated by the lower ultrasound intensities produces a synergistic effect with the self-transfer of liposomes. PEI has a high density of positive charges and has been shown to interact with the negatively charged cell membrane and enter the cell through endocytosis. USMT does not produce a synergistic effect with the endocytosis of PEI.
The present study showed that rAAV, pDNA and L/siRNA in combination with MBs, but without US, did not increase transfection efficiency. One study on the comparison between the effect of different microbubble contrast agents on gene transfection showed that Optison improved pDNA transfection efficiency into skeletal muscles of mice but that SonoVue and Levovist did not (22). A previous study also found that SonoVue alone enhanced rAAV transfection efficiency to RPE-J cells (14). The nonspecific phagocytic ability of cells to phagocytize MBs may be the key factor underlying this phenomenon.
UTMD significantly increased rAAV and PEI/pDNA transfer to human RPE cells. MBs acting as cavitation nuclei effectively focus US energy and potentiate further bioeffects (23). Therefore, using UTMD, the energy produced is sufficient for the formation of transient pores in ARPE-19 cells. Although UTMD significantly increased L/siRNA transfection, its efficiency was lower than that of US exposure alone. Endocytosis induced by the low energy of US alone was more effective in L/siRNA transfection than sonoporation induced by the higher energy UTMD.
UTMD/US enhanced the transfection efficiency of rAAV, PEI/pDNA and L/siRNA by increasing the transgene expression per cell and the percentage of transfected cells. UTMD-mediated rAAV or PEI/pDNA delivery was more effective than that of L/siRNA. In the present study, the percentage of positively transfected cells increased to 74.88±11.03% and transgene expression per cell increased to 71.46±8.58%. In RPE cells, higher transgene expression per cell was more important than higher percentages of positive cells. Due to the small size of the retinal cells and short distance between RPE and the neural retina, a small number of transfected RPE cells may provide sufficient levels of a potent secreted protein to produce successful retinal gene therapy (24). A very small number of transfected cells (<0.1%) was adequate for therapeutic efficacy of secreted gene product, vascular endothelial growth factor, in the vascular wall (25).
The effect of different UTMD parameters on the transfection ability of rAAV, PEI/pDNA and L/siRNA in cells was also evaluated. No significant difference was detected between the exposure groups and the control groups. Thus, UTMD had no apparent effect on the transfection ability of rAAV, PEI/pDNA and L/siRNA. Furthermore, agarose gel electrophoresis showed that UTMD did not alter the structure of pDNA in the supernatant.
In conclusion, the present study demonstrated that UTMD/US may be used to enhance rAAV, PEI/pDNA and L/siRNA transfection efficiency of ARPE-19 cells in vitro. Studies on different genes (including pDNA and siRNA) and different types of vectors (chemical and biological) mediated by UTMD may provide useful information for future in vivo and transfection studies.
Acknowledgements
This study was supported by the National Natural Science Foundation of China (grant no. 81200700) and the Natural Science Foundation of Shanghai (grant no. 11ZR1421100).
References
Algvere PV, Berglin L, Gouras P and Sheng Y: Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. 232:707–716. 1994. View Article : Google Scholar : PubMed/NCBI | |
Li LX and Turner JE: Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp Eye Res. 47:911–917. 1988. View Article : Google Scholar : PubMed/NCBI | |
Sunshine JC, Sunshine SB, Bhutto I, Handa JT and Green JJ: Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS One. 7:e375432012. View Article : Google Scholar | |
del Pozo-Rodriguez A, Delgado D, Solinis MA, Gascón AR and Pedraz JL: Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. Int J Pharm. 360:177–183. 2008. View Article : Google Scholar : PubMed/NCBI | |
Urtti A, Polansky J, Lui GM and Szoka FC: Gene delivery and expression in human retinal pigment epithelial cells: effects of synthetic carriers, serum, extracellular matrix and viral promoters. J Drug Target. 7:413–421. 2000. View Article : Google Scholar : PubMed/NCBI | |
Abul-Hassan K, Walmsley R and Boulton M: Optimization of non-viral gene transfer to human primary retinal pigment epithelial cells. Curr Eye Res. 20:361–366. 2000. View Article : Google Scholar : PubMed/NCBI | |
Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL and Zimmer SG: Transfection of mammalian cells With plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci USA. 84:8463–8467. 1987. View Article : Google Scholar : PubMed/NCBI | |
Zhou XY, Liao Q, Pu YM, Tang YQ, Gong X, Li J, Xu Y and Wang ZG: Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin Med J. 22:2711–2717. 2009. | |
Sonoda S, Tachibana K, Yamashita T, Shirasawa M, Terasaki H, Uchino E, Suzuki R, Maruyama K and Sakamoto T: Selective gene transfer to the retina using intravitreal ultrasound irradiation. J Ophthalmol. 12:4127522012. | |
Sanders NN, Peeters L, Lentacker I, Demeester J and De Smedt SC: Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer. J Control Release. 122:226–235. 2007. View Article : Google Scholar : PubMed/NCBI | |
Xie W, Liu S, Su H, Wang Z, Zheng Y and Fu Y: Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo. Acad Radiol. 17:1242–1248. 2010. View Article : Google Scholar : PubMed/NCBI | |
Li HL, Zheng XZ, Wang HP, Li F, Wu Y and Du LF: Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther. 16:1146–1153. 2009. View Article : Google Scholar : PubMed/NCBI | |
Zheng XZ, Wu Y, Li HL, Du LF, Wang HP and Gu Q: Comparative analysis of the effects of ultrasound-targeted microbubble destruction on recombinant adeno-associated virus- and plasmid-mediated transgene expression in human retinal pigment epithelium cells. Mol Med Rep. 2:937–942. 2009.PubMed/NCBI | |
Zheng XZ, Li HL, Du LF, Wang HP and Gu Q: Comparative analysis of gene transfer to human and rat retinal pigment epithelium cell line by a combinatorial use of recombinant adeno-associated virus and ultrasound or/and microbubbles. Bosn J Basic Med Sci. 9:174–181. 2009.PubMed/NCBI | |
Mannermaa E, Rönkkö S, Ruponen M, Reinisalo M and Urtti A: Long-lasting secretion of transgene product from differentiated and filter-grown retinal pigment epithelial cells after nonviral gene transfer. Curr Eye Res. 30:345–353. 2005. View Article : Google Scholar : PubMed/NCBI | |
Müller OJ, Schinkel S, Kleinschmidt JA, Katus HA and Bekeredjian R: Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther. 15:1558–1565. 2008. View Article : Google Scholar : PubMed/NCBI | |
Zhang CB, Cao HL, Li Q, Tu J, Guo X, Liu Z and Zhang D: Enhancement effect of ultrasound-induced microbubble cavitation on branched polyethylenimine-mediated VEGF (165) transfection with varied N/P ratio. Ultrasound Med Biol. 39:161–171. 2013. View Article : Google Scholar | |
Afadzi M, Strand SP, Nilssen EA, Måsøy SE, Johansen TF, Hansen R, Angelsen BA and de Davies LC: Mechanisms of the ultrasound-mediated intracellular delivery of liposomes and dextrans. IEEE Trans Utrason Ferroelectr Freq Control. 60:21–33. 2013. | |
Geers B, Lentacker I, Alonso A, Sanders NN, Demeester J, Meairs S and De Smedt SC: Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles. Mol Pharm. 8:2244–2251. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lee JL, Lo CW, Ka SM, Chen A and Chen WS: Prolonging the expression duration of ultrasound-mediated gene transfection using PEI nanoparticles. J Control Release. 160:64–71. 2012. View Article : Google Scholar : PubMed/NCBI | |
Juffermans LJ, Meijering BD, Henning RH and Deelman LE: Ultrasound and microbubble-targeted delivery of small interfering RNA into primary endothelial cells is more effective than delivery of plasmid DNA. Ultrasound Med Biol. 40:532–40. 2014. View Article : Google Scholar | |
Wang X, Liang HD, Dong B, Lu QL and Blomley MJ: Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents. Radiology. 237:224–229. 2005. View Article : Google Scholar : PubMed/NCBI | |
Okada K, Kudo N, Niwa K and Yamamoto K: A basic study on sonoporation with microbubbles exposed to pulsed ultrasound. J Med Ultrasonics. 32:3–11. 2005. View Article : Google Scholar | |
Haensler J and Szoka FC Jr: Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem. 4:372–379. 1993. View Article : Google Scholar : PubMed/NCBI | |
Laitinen M, Zachary I, Breier G, et al: VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther. 8:1737–1744. 1997. View Article : Google Scholar : PubMed/NCBI |